KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Retained Earnings (2016 - 2025)

Gilead Sciences' Retained Earnings history spans 17 years, with the latest figure at $39.0 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 70.45% year-over-year to $39.0 million; the TTM value through Dec 2025 reached $39.0 million, down 70.45%, while the annual FY2025 figure was $39.0 million, 70.45% down from the prior year.
  • Retained Earnings reached $39.0 million in Q4 2025 per GILD's latest filing, up from $36.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $16.9 billion in Q3 2021 to a low of -$20.0 million in Q1 2023.
  • Average Retained Earnings over 5 years is $7.3 billion, with a median of $5.4 billion recorded in 2024.
  • Peak YoY movement for Retained Earnings: soared 73391.3% in 2021, then plummeted 119.35% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $83.0 million in 2021, then surged by 18800.0% to $15.7 billion in 2022, then tumbled by 99.82% to $28.0 million in 2023, then skyrocketed by 371.43% to $132.0 million in 2024, then crashed by 70.45% to $39.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Retained Earnings are $39.0 million (Q4 2025), $36.0 million (Q3 2025), and -$18.0 million (Q2 2025).